Anna Griego

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Pulmonary Tuberculosis

Crystal Structure

Antimicrobial Resistance

Top Venues

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Matteo Mori, Giovanni Stelitano, Giulia Cazzaniga, Arianna Gelain, Andrea Tresoldi, Mario Cocorullo, Martina Roversi, Laurent Roberto Chiarelli, Martina Tomaiuolo, Pietro Delre, Giuseppe Felice Mangiatordi, Anna Griego, Loris Rizzello, Alberto Cassetta, Sonia Covaceuszach, Stefania Villa, Fiorella Meneghetti
Targeting Siderophore-Mediated Iron Uptake in M. abscessus : A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria. Pharmaceutics 15 (2) (2023)
Matteo Mori, Giovanni Stelitano, Giulia Cazzaniga, Arianna Gelain, Andrea Tresoldi, Mario Cocorullo, Martina Roversi, Laurent Roberto Chiarelli, Martina Tomaiuolo, Pietro Delre, Giuseppe Felice Mangiatordi, Anna Griego, Loris Rizzello, Alberto Cassetta, Sonia Covaceuszach, Stefania Villa, Fiorella Meneghetti
Targeting Siderophore-Mediated Iron Uptake in M. abscessus : A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria. Pharmaceutics 15 (2) (2023)
Matteo Mori, Giovanni Stelitano, Giulia Cazzaniga, Arianna Gelain, Andrea Tresoldi, Mario Cocorullo, Martina Roversi, Laurent Roberto Chiarelli, Martina Tomaiuolo, Pietro Delre, Giuseppe Felice Mangiatordi, Anna Griego, Loris Rizzello, Alberto Cassetta, Sonia Covaceuszach, Stefania Villa, Fiorella Meneghetti
Targeting Siderophore-Mediated Iron Uptake in M. abscessus : A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria. Pharmaceutics 15 (2) (2023)
Matteo Mori, Giovanni Stelitano, Anna Griego, Laurent Roberto Chiarelli, Giulia Cazzaniga, Arianna Gelain, Elena Pini, Marina Camera, Paola Canzano, Andrea Fumagalli, Edoardo Scarpa, Chiara Cordiglieri, Loris Rizzello, Stefania Villa, Fiorella Meneghetti
Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections. Pharmaceuticals (Basel, Switzerland) 15 (8) (2022)